Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
53
ICHR Quote, Financials, Valuation and Earnings
Last price:
$45.30
Seasonality move
:
-7.76%
Day range:
$40.39 - $47.46
52-week range:
$13.12 - $47.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.64x
P/B ratio:
2.35x
Volume:
5.7M
Avg. volume:
1.1M
1-year change:
32.91%
Market cap:
$1.6B
Revenue:
$947.7M
EPS (TTM):
-$1.54
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $811.1M | $849M | $947.7M | |
| Revenue Growth (YoY) | 19.98% | 16.7% | -36.64% | 4.68% | 11.62% | |
| Cost of Revenues | $931.7M | $1.1B | $722.5M | $754.3M | $868.2M | |
| Gross Profit | $165.2M | $194M | $88.7M | $94.8M | $79.5M | |
| Gross Profit Margin | 15.06% | 15.15% | 10.93% | 11.16% | 8.39% | |
| R&D Expenses | $15.7M | $19.6M | $20.2M | $23M | $23.1M | |
| Selling, General & Admin | $65.9M | $88.6M | $79.3M | $79.4M | -- | |
| Other Inc / (Exp) | -$807K | $563K | -$804K | -$1.1M | -- | |
| Operating Expenses | $76.8M | $103.7M | $99.6M | $102.4M | $118.7M | |
| Operating Income | $88.4M | $90.3M | -$10.9M | -$7.6M | -$39.3M | |
| Net Interest Expenses | $6.5M | $11.1M | $19.4M | $9.3M | $6.6M | |
| EBT. Incl. Unusual Items | $73.8M | $75.3M | -$31.1M | -$18.1M | -$47.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.9M | $2.5M | $11.9M | $2.8M | $5.2M | |
| Net Income to Company | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Basic EPS (Cont. Ops) | $2.51 | $2.54 | -$1.47 | -$0.64 | -$1.54 | |
| Diluted EPS (Cont. Ops) | $2.45 | $2.51 | -$1.47 | -$0.64 | -$1.54 | |
| Weighted Average Basic Share | $28.3M | $28.7M | $29.2M | $32.8M | $34.2M | |
| Weighted Average Diluted Share | $29M | $29M | $29.2M | $32.8M | $34.2M | |
| EBITDA | $114.4M | $125.4M | $23.7M | $23.1M | -$5.8M | |
| EBIT | $88.4M | $90.3M | -$10.9M | -$7.6M | -$39.3M | |
| Revenue (Reported) | $1.1B | $1.3B | $811.1M | $849M | $947.7M | |
| Operating Income (Reported) | $88.4M | $90.3M | -$10.9M | -$7.6M | -$39.3M | |
| Operating Income (Adjusted) | $88.4M | $90.3M | -$10.9M | -$7.6M | -$39.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $287.2M | $301.7M | $203.5M | $233.3M | $223.6M | |
| Revenue Growth (YoY) | 17.24% | 5.06% | -32.56% | 14.65% | -4.15% | |
| Cost of Revenues | $244.6M | $256.8M | $186.3M | $208.6M | $204.7M | |
| Gross Profit | $42.5M | $45M | $17.2M | $24.7M | $18.9M | |
| Gross Profit Margin | 14.81% | 14.9% | 8.44% | 10.6% | 8.45% | |
| R&D Expenses | $4.2M | $4.9M | $5.5M | $5.9M | $5.6M | |
| Selling, General & Admin | $21.7M | $22M | $19.6M | $20.1M | -- | |
| Other Inc / (Exp) | -$704K | -$111K | $109K | -$272K | -- | |
| Operating Expenses | $21.5M | $27M | $25.1M | $26M | $32.7M | |
| Operating Income | $21M | $18M | -$8M | -$1.3M | -$13.8M | |
| Net Interest Expenses | $1.5M | $4.2M | $4.7M | $1.7M | $1.7M | |
| EBT. Incl. Unusual Items | $14.2M | $13.7M | -$12.5M | -$3.2M | -$15.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$672K | -$505K | -$614K | $745K | $132K | |
| Net Income to Company | $14.9M | $14.2M | -$11.9M | -$3.9M | -$16M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.9M | $14.2M | -$11.9M | -$3.9M | -$16M | |
| Basic EPS (Cont. Ops) | $0.52 | $0.49 | -$0.40 | -$0.12 | -$0.46 | |
| Diluted EPS (Cont. Ops) | $0.51 | $0.49 | -$0.40 | -$0.12 | -$0.46 | |
| Weighted Average Basic Share | $28.5M | $28.8M | $29.4M | $33.8M | $34.4M | |
| Weighted Average Diluted Share | $29M | $29M | $29.4M | $33.8M | $34.4M | |
| EBITDA | $29.4M | $26.4M | $582K | $6.7M | -$3.8M | |
| EBIT | $21M | $18M | -$8M | -$1.3M | -$13.8M | |
| Revenue (Reported) | $287.2M | $301.7M | $203.5M | $233.3M | $223.6M | |
| Operating Income (Reported) | $21M | $18M | -$8M | -$1.3M | -$13.8M | |
| Operating Income (Adjusted) | $21M | $18M | -$8M | -$1.3M | -$13.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $811.1M | $849M | $947.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $933.9M | $1.1B | $722.5M | $754.3M | $868.6M | |
| Gross Profit | $163M | $194M | $88.7M | $94.8M | $79.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $15.7M | $19.6M | $20.2M | $23M | $23.1M | |
| Selling, General & Admin | $65.9M | $88.6M | $79.3M | $79.4M | $68.5M | |
| Other Inc / (Exp) | -$807K | $563K | -$804K | -$1.1M | -- | |
| Operating Expenses | $77.2M | $103.7M | $99.6M | $102.4M | $99.4M | |
| Operating Income | $85.9M | $90.3M | -$10.9M | -$7.6M | -$20.3M | |
| Net Interest Expenses | $6.5M | $11.1M | $19.4M | $9.3M | $6.6M | |
| EBT. Incl. Unusual Items | $73.8M | $75.3M | -$31.1M | -$18.1M | -$47.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.9M | $2.5M | $11.9M | $2.8M | $5.2M | |
| Net Income to Company | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Basic EPS (Cont. Ops) | $2.51 | $2.53 | -$1.47 | -$0.65 | -$1.54 | |
| Diluted EPS (Cont. Ops) | $2.45 | $2.51 | -$1.47 | -$0.65 | -$1.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $111.9M | $125.4M | $23.7M | $29.4M | $15.3M | |
| EBIT | $85.9M | $90.3M | -$10.9M | -$7.6M | -$20.3M | |
| Revenue (Reported) | $1.1B | $1.3B | $811.1M | $849M | $947.7M | |
| Operating Income (Reported) | $85.9M | $90.3M | -$10.9M | -$7.6M | -$20.3M | |
| Operating Income (Adjusted) | $85.9M | $90.3M | -$10.9M | -$7.6M | -$20.3M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $811.1M | $849M | $947.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $722.5M | $754.3M | $868.6M | -- | |
| Gross Profit | $194M | $88.7M | $94.8M | $79.1M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $19.6M | $20.2M | $23M | $23.1M | -- | |
| Selling, General & Admin | $88.6M | $79.3M | $79.4M | $68.5M | -- | |
| Other Inc / (Exp) | $563K | -$804K | -$1.1M | -$274K | -- | |
| Operating Expenses | $103.7M | $99.6M | $102.4M | $99.4M | -- | |
| Operating Income | $90.3M | -$10.9M | -$7.6M | -$20.3M | -- | |
| Net Interest Expenses | $11.1M | $19.4M | $9.3M | $6.6M | -- | |
| EBT. Incl. Unusual Items | $75.3M | -$31.1M | -$18.1M | -$47.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5M | $11.9M | $2.8M | $5.2M | -- | |
| Net Income to Company | $72.8M | -$43M | -$20.8M | -$52.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $72.8M | -$43M | -$20.8M | -$52.8M | -- | |
| Basic EPS (Cont. Ops) | $2.53 | -$1.47 | -$0.65 | -$1.54 | -- | |
| Diluted EPS (Cont. Ops) | $2.51 | -$1.47 | -$0.65 | -$1.54 | -- | |
| Weighted Average Basic Share | $114.9M | $116.8M | $131M | $136.9M | -- | |
| Weighted Average Diluted Share | $116.2M | $116.8M | $131M | $136.9M | -- | |
| EBITDA | $125.4M | $23.7M | $29.4M | $15.3M | -- | |
| EBIT | $90.3M | -$10.9M | -$7.6M | -$20.3M | -- | |
| Revenue (Reported) | $1.3B | $811.1M | $849M | $947.7M | -- | |
| Operating Income (Reported) | $90.3M | -$10.9M | -$7.6M | -$20.3M | -- | |
| Operating Income (Adjusted) | $90.3M | -$10.9M | -$7.6M | -$20.3M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $143M | $136.3M | $66.7M | $86.6M | $70.5M | |
| Inventory | $236.1M | $283.7M | $245.9M | $250.1M | $231.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $8.2M | $7M | $8.8M | $7.2M | -- | |
| Total Current Assets | $462.8M | $513.5M | $401.4M | $452.6M | $410.1M | |
| Property Plant And Equipment | $115M | $138.6M | $129.4M | $139.3M | $139M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $335.9M | $335.4M | $335.4M | $335.4M | -- | |
| Other Intangibles | $89.9M | $72M | $57.3M | $48.7M | -- | |
| Other Long-Term Assets | $9.2M | $12.9M | $11.9M | $15.2M | -- | |
| Total Assets | $1B | $1.1B | $938.5M | $995.6M | $942.9M | |
| Accounts Payable | $159.7M | $110.2M | $60.5M | $91.7M | $84M | |
| Accrued Expenses | $19.1M | $23.6M | $14.9M | $16M | -- | |
| Current Portion Of Long-Term Debt | $7.5M | $7.5M | $7.5M | $7.5M | -- | |
| Current Portion Of Capital Lease Obligations | $7.6M | $9.2M | $9.5M | $11.5M | -- | |
| Other Current Liabilities | $14.4M | $15.8M | $6.6M | $9M | -- | |
| Total Current Liabilities | $208.3M | $166.3M | $99M | $135.7M | $129.6M | |
| Long-Term Debt | $307.6M | $325M | $269.4M | $155.2M | $142.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $520.2M | $496.2M | $373.8M | $297.2M | $279M | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $500.7M | $587.5M | $564.7M | $698.3M | $663.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $500.7M | $587.5M | $564.7M | $698.3M | $663.9M | |
| Total Liabilities and Equity | $1B | $1.1B | $938.5M | $995.6M | $942.9M | |
| Cash and Short Terms | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Total Debt | $315.1M | $332.5M | $276.9M | $162.7M | $148.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $143M | $136.3M | $66.7M | $86.6M | $70.5M | |
| Inventory | $236.1M | $283.7M | $245.9M | $250.1M | $231.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $8.2M | $7M | $8.8M | $7.2M | -- | |
| Total Current Assets | $462.8M | $513.5M | $401.4M | $452.6M | $410.1M | |
| Property Plant And Equipment | $115M | $138.6M | $129.4M | $139.3M | $139M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $335.9M | $335.4M | $335.4M | $335.4M | -- | |
| Other Intangibles | $89.9M | $72M | $57.3M | $48.7M | -- | |
| Other Long-Term Assets | $9.2M | $12.9M | $11.9M | $15.2M | -- | |
| Total Assets | $1B | $1.1B | $938.5M | $995.6M | $942.9M | |
| Accounts Payable | $159.7M | $110.2M | $60.5M | $91.7M | $84M | |
| Accrued Expenses | $19.1M | $23.6M | $14.9M | $16M | -- | |
| Current Portion Of Long-Term Debt | $7.5M | $7.5M | $7.5M | $7.5M | -- | |
| Current Portion Of Capital Lease Obligations | $7.6M | $9.2M | $9.5M | $11.5M | -- | |
| Other Current Liabilities | $14.4M | $15.8M | $6.6M | $9M | -- | |
| Total Current Liabilities | $208.3M | $166.3M | $99M | $135.7M | $129.6M | |
| Long-Term Debt | $307.6M | $325M | $269.4M | $155.2M | $142.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $520.2M | $496.2M | $373.8M | $297.2M | $279M | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $500.7M | $587.5M | $564.7M | $698.3M | $663.9M | |
| Total Liabilities and Equity | $1B | $1.1B | $938.5M | $995.6M | $942.9M | |
| Cash and Short Terms | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Total Debt | $315.1M | $332.5M | $276.9M | $162.7M | $148.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Depreciation & Amoritzation | $26M | $35.1M | $34.6M | $30.7M | $33.5M | |
| Stock-Based Compensation | $11.5M | $13.9M | $17.3M | $15.6M | $16.7M | |
| Change in Accounts Receivable | -$33.5M | $6.7M | $69.6M | -$19.9M | $16.1M | |
| Change in Inventories | -$89.2M | -$47.5M | $37.8M | -$4.2M | -$1.5M | |
| Cash From Operations | $15.3M | $31.5M | $57.6M | $27.9M | $29.9M | |
| Capital Expenditures | $20.8M | $29.4M | $15.5M | $17.6M | $36.2M | |
| Cash Acquisitions | $268.8M | -- | -- | -- | -- | |
| Cash From Investing | -$289.6M | -$28.9M | -$15.5M | -$17.6M | -$36.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $231.8M | $25M | -- | -- | -- | |
| Long-Term Debt Repaid | -$139.1M | -$17.5M | -$52.5M | -$120.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.5M | -$2.8M | -$3.7M | -$5.4M | -- | |
| Cash From Financing | $96.9M | $8.5M | -$48.7M | $18.5M | -$4.1M | |
| Beginning Cash (CF) | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$177.4M | $11M | -$6.5M | $28.7M | -$10.4M | |
| Ending Cash (CF) | -$101.9M | $97.4M | $73.4M | $137.4M | $87.9M | |
| Levered Free Cash Flow | -$5.6M | $2M | $42.1M | $10.2M | -$6.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.9M | $14.2M | -$11.9M | -$3.9M | -$16M | |
| Depreciation & Amoritzation | $8.3M | $8.4M | $8.5M | $8M | $10M | |
| Stock-Based Compensation | $3.4M | $3.8M | $4.7M | $4.6M | $4.2M | |
| Change in Accounts Receivable | -$12.8M | $47M | $36.6M | -$2.5M | $13.9M | |
| Change in Inventories | -$30.1M | $7M | $21M | -$10.7M | $6.8M | |
| Cash From Operations | -$9.1M | $38.8M | $37.6M | -$2.5M | $9.2M | |
| Capital Expenditures | $2.1M | $7M | $2.3M | $4.4M | $3.2M | |
| Cash Acquisitions | $268.8M | -- | -- | -- | -- | |
| Cash From Investing | -$172.4M | -$7M | -$2.3M | -$4.4M | -$3.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $231.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$102.5M | -$1.9M | -$31.9M | -$1.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.9M | -$592K | -$790K | -$1.2M | -- | |
| Cash From Financing | $128.9M | -$1.8M | -$31.3M | -$892K | -$131K | |
| Beginning Cash (CF) | $75.5M | $86.5M | $80M | $108.7M | $98.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$52.5M | $30M | $4M | -$7.8M | $5.8M | |
| Ending Cash (CF) | $23M | $116.5M | $84M | $100.9M | $104.1M | |
| Levered Free Cash Flow | -$11.3M | $31.8M | $35.3M | -$6.9M | $5.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $70.9M | $72.8M | -$43M | -$20.8M | -$52.8M | |
| Depreciation & Amoritzation | $26M | $35.1M | $34.6M | $30.7M | $33.5M | |
| Stock-Based Compensation | $11.5M | $13.9M | $17.3M | $15.6M | $16.7M | |
| Change in Accounts Receivable | -$33.5M | $6.7M | $69.6M | -$19.9M | $16.1M | |
| Change in Inventories | -$89.2M | -$47.5M | $37.8M | -$4.2M | -$1.5M | |
| Cash From Operations | $15.3M | $31.5M | $57.6M | $27.9M | $29.9M | |
| Capital Expenditures | $20.8M | $29.4M | $15.5M | $17.6M | $36.2M | |
| Cash Acquisitions | $268.8M | -- | -- | -- | -- | |
| Cash From Investing | -$289.6M | -$28.9M | -$15.5M | -$17.6M | -$36.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$139.1M | -$17.5M | -$52.5M | -$120.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.5M | -$2.8M | -$3.7M | -$5.4M | -- | |
| Cash From Financing | $96.9M | $8.5M | -$48.7M | $18.5M | -$4.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$177.4M | $11M | -$6.5M | $28.7M | -$10.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5.6M | $2M | $42.1M | $10.2M | -$6.3M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $72.8M | -$43M | -$20.8M | -$52.8M | -- | |
| Depreciation & Amoritzation | $35.1M | $34.6M | $30.7M | $33.5M | -- | |
| Stock-Based Compensation | $13.9M | $17.3M | $15.6M | $16.7M | -- | |
| Change in Accounts Receivable | $6.7M | $69.6M | -$19.9M | $16.1M | -- | |
| Change in Inventories | -$47.5M | $37.8M | -$4.2M | -$1.5M | -- | |
| Cash From Operations | $31.5M | $57.6M | $27.9M | $29.9M | -- | |
| Capital Expenditures | $29.4M | $15.5M | $17.6M | $36.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$28.9M | -$15.5M | -$17.6M | -$36.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $25M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$17.5M | -$52.5M | -$120.6M | -$3.8M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.8M | -$3.7M | -$5.4M | -$3M | -- | |
| Cash From Financing | $8.5M | -$48.7M | $18.5M | -$4.1M | -- | |
| Beginning Cash (CF) | $223.5M | $309.3M | $441.6M | $392.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11M | -$6.5M | $28.7M | -$10.4M | -- | |
| Ending Cash (CF) | $234.5M | $302.8M | $470.3M | $381.9M | -- | |
| Levered Free Cash Flow | $2M | $42.1M | $10.2M | -$6.3M | -- | |
Get ICHR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ICHR
Sector
P/E ratio
--
24.38x
PEG ratio
-0.22x
0.00x
P/B ratio
2.35x
2.17x
Price / LTM sales
1.64x
1.40x
Growth Metrics
ICHR
Sector
Revenue growth
-4.15%
6.35%
Earnings growth
-297.52%
9.35%
Revenue (5-year growth)
0.72%
4.89%
Earnings forecast
-$0.06
$0.14
Profitability
ICHR
Sector
Profitability FY 2025
$79.5M
$28.3M
Return on invested capital
-6.19%
-0.74%
Return on assets
-5.39%
-1.59%
Return on equity
-7.69%
0.14%
Earnings Date
Last Earnings Date
Feb
9
Next Earnings Date
May
4
Estimated Next Earnings Date
May
11
Balance Sheet
ICHR
Sector
Total cash
$98.3M
$38.6M
Short term investments
--
$16.1M
Total assets
$942.9M
$149.3M
Long term debt
$148.9M
$3.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 12.71% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 1.26% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 3.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
